Iveacare
Roseville, US · Founded 2023 · 3 known investors
IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations. The company partners with physicians to advance new therapies in the treatment of unmet clinical needs.
Deep TechHealthtechMedical Devices
Founders & leadership
CD
Corey DishmonDirector
TK
Todd KerkowCo-Founder, President and CEO
MJ
Mudit JainCo-Founder and Chairman of the Board
RG
Robert GreenbergDirector
KN
Kirk NielsenDirector
AS
Amrinder SinghDirector
TP
Tracy PappasDirector
DR
Doug ReedDirector
L
LynnCo-Founder and Board Member
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$15.5MraisedApr 2024 · 5 investors · Other Health CareRule 506(b)
▶$15.5MraisedApr 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Corey DishmonDirector
- Todd KerkowExecutive Officer, Director
- Mudit JainExecutive Officer, Director
- Robert GreenbergDirector
- Kirk NielsenDirector
- Amrinder SinghDirector
- Tracy PappasDirector
- Doug ReedDirector
- Offering amount
- $27.6M
- Amount sold
- $15.5M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Roseville-based medical device company iVEAcare raises $27.5 million in Series A funding round - Minneapolis / St. Paul Business Journalbizjournals.com · 2024
- Fueling Innovation: iVEAcare Raises $27.5M to Advance Neuromodulation Therapyswansonreed.com · 2024
- iVEAcare Launches with $27.5 Million in Series A Funding from Leading Medtech Investors - Vensana Capitalvensanacap.com · 2024
- Neuromod startup IVEAcare raises $27.5M, names CEOmassdevice.com · 2024
- iVEAcare Raises $27.5M in Series A Fundingfinsmes.com · 2024